Bulk Generic Medicines Supplier from India for United States Importers

Why US Buyers Look to India for Bulk Generic Medicines

India is one of the world's largest sources of finished generic formulations, and US wholesalers, distributors, hospital buying groups and pharmacy chains keep it in their sourcing mix for cost, range and manufacturing scale. The United States is also one of the most tightly regulated pharmaceutical markets. Buying from an Indian pharmaceutical exporter works only if every product, facility and shipment fits the US legal framework.

This guide is for importers and distributors comparing suppliers. It covers what the US Food and Drug Administration (FDA) expects, which documents a serious exporter should provide, and how a typical bulk order moves from enquiry to delivery.

Start With the Regulatory Reality

In the US, prescription generic medicines must be lawfully marketed, which usually means an approved Abbreviated New Drug Application (ANDA) held by the manufacturer or its US partner. Some products are sold over the counter under an applicable monograph. Before you compare prices, confirm which category each product falls into.

The main building blocks are:

• Product status: an FDA-approved ANDA or another lawful marketing pathway for the exact strength and dosage form.
• Facility registration: the manufacturing site must be registered with the FDA, and products must be listed. Sites can be inspected by the agency.
• Importer of record: a US-based party responsible for the customs entry and for compliance on arrival.
• Labeler identification: products are identified with National Drug Codes (NDC) under the labeler responsible for the product.
• State licensing: wholesale distributors and third-party logistics providers generally need licences from the relevant state boards of pharmacy or equivalent authorities.

Rules and agency practices change. Confirm current requirements directly with the FDA and your state regulators, and ideally with a US regulatory consultant or customs broker, before you place a first order. Our insights library has other market guides that explain how documentation requirements vary between countries.

What a Merchant Exporter Does and Does Not Do

Tuli Enterprise is a New Delhi-based merchant exporter. We source finished formulations from GMP-certified manufacturing partners, coordinate documentation, consolidate orders and manage export logistics. We do not replace your own regulatory responsibilities as an importer. We will not suggest that a product can be sold in the US market if it lacks the required approval status, and a responsible buyer should be wary of any supplier that does.

In practice, we help US-focused buyers in several ways:

• Checking which products in our range are supplied by partners with US-oriented manufacturing and quality systems.
• Providing technical documents to support your own compliance review.
• Coordinating packaging, labelling and shipment details with the manufacturing partner.
• Supporting buyers who need private-label or custom production, where regulatory ownership is agreed in writing from the start.

Documents to Request From Any Indian Supplier

A professional exporter should provide a clear documentation pack. Ask for the following, and review it with your quality or regulatory team:

1. Certificate of Analysis (CoA) for each batch, with test methods and specifications.
2. Certificate of Pharmaceutical Product (COPP) where available from the Indian licensing authority.
3. Free Sale Certificate showing that the product is lawfully sold in India.
4. Stability data supporting the proposed shelf life and storage conditions.
5. CTD-format dossier extracts or technical documentation, useful for quality reviews and market registrations elsewhere.
6. Manufacturing partner details, including site address and quality certification evidence, so you can verify the facility independently.
7. Commercial invoice, packing list and airway bill or bill of lading for customs clearance.

For a deeper look at how these papers fit together, see our explainer on pharmaceutical import documentation in the insights section.

Choosing Products and Therapy Areas

Start with products where supply is stable and the regulatory status is clear. Typical categories for wholesale generic buyers include anti-infectives, cardiovascular medicines, diabetes and metabolic products, respiratory therapies, gastrointestinal products and analgesics. You can browse our full product catalogue or filter by therapy area to shortlist molecules, dosage forms and strengths for your RFQ.

When you send a shortlist, include the exact strength, dosage form, pack size and any pharmacopoeial standard you need (for example USP). The more specific the request, the faster a partner can confirm feasibility.

MOQ, Pricing and Lead Time: What to Expect

Minimum order quantities depend on the product, the dosage form and the manufacturing partner. Standard catalogue items are generally easier to supply in smaller consolidated quantities. Customised packaging or private-label runs usually require larger batches. Lead time depends on stock availability, batch scheduling, quality release and shipping mode, so we confirm it per quotation rather than quote a blanket figure.

Pricing is typically quoted on an Incoterm basis such as FOB, CIF or DAP. For US shipments, agree in advance who handles customs clearance, who acts as importer of record, and who bears the risk during transit. Temperature-sensitive products need validated packaging and a clear plan for transit delays.

Labelling, Serialization and Traceability

US labelling is closely regulated. Labels, package inserts, NDC placement and product identifiers must match the approved labelling for the product. The Drug Supply Chain Security Act (DSCSA) also sets expectations for product tracing and verification in the US supply chain. Raise these requirements at the first enquiry, not after production, because they affect artwork, packaging lines and shipment documentation.

A Practical Sourcing Workflow

1. Define scope: list products, strengths, pack sizes and annual volumes.
2. Confirm regulatory status: verify ANDA or other lawful status and the facility's FDA standing for each item.
3. Request the documentation pack: CoA, COPP, stability data and dossier extracts.
4. Quality review: audit the partner facility or commission a third-party assessment where needed.
5. Sample and specification check: test samples through your own laboratory where appropriate.
6. Commercial terms: agree Incoterms, payment terms, labelling responsibilities and lead time in writing.
7. Shipment and clearance: coordinate with your customs broker and importer of record.

Private Label and Contract Manufacturing

Some US buyers want their own brand or a specific presentation. Our contract manufacturing service connects you with qualified partners for third-party production. For the US market, the regulatory ownership of each product (who holds the application, who is the labeler, who handles pharmacovigilance) must be decided before production begins.

Red Flags to Avoid

• Suppliers who promise US market access without discussing FDA approval status.
• Missing or generic CoAs that lack batch numbers and test results.
• Unwillingness to name the manufacturing site or allow a quality audit.
• Pricing that is far below the market with no explanation.

Request a Quote

If you are evaluating an Indian pharmaceutical supplier for the United States, send us your product list, target volumes and any labelling or packaging requirements through our contact page. You can also message our export team on WhatsApp at +91 96543 08142 or email [email protected], and we will respond with documentation availability, MOQ guidance and an indicative lead time for your shortlist.